Healthy Participant

2

Review clinical trials related to Healthy Participant. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women

This study aims to figure out how much etrasimod, a medication, ends up in breast milk after taking it for several days. To do this, the researchers will work with at least 8 healthy women who are breastfeeding. These women will take a 2 mg dose of etrasimod every day for 7 days while staying at the testing site. During the study, they won't be allowed to breastfeed their babies to keep the babies safe. Instead, they need to have another plan for feeding their babies during this time. The study will look at how the medication is absorbed and how it moves through the body, checking things like the highest level in the blood and how long it takes to reach that level. The researchers will also see how much of the drug is in the breast milk compared to the blood and whether it's safe for the women to take. After the last dose, the women will stay at the site for at least another 24 hours before going home, and follow-up safety calls will be made about 14 and 28 to 35 days later. The whole process from start to finish will take about 10 weeks

Participants needed: 8
Trial details
Phase: Phase 1Age: 18-55Biological sex: FemaleType: InterventionalSponsor: PfizerUpdated: Apr 7, 2026Locations: 1
Eligibility criteria

Healthy (as determined by medical evaluation including medical history, physical... [+10]

Status: Recruiting

A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adults and Cancer Survivors

This Phase 2a clinical study (GIANTS-1) aims to evaluate a novel dual-combination strategy using GI-102 and GIB-7 to address key pathological features of aging, including immunosenescence (the aging of the immune system), metabolic dysfunction, and gut-brain-muscle axis dysregulation.

Participants needed: 15
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: GI Innovation, Inc.Updated: Jan 26, 2026Locations: 2
Eligibility criteria

Must be aged between ≥18 and ≤80 years old at the time of informed consent. [+7]

Severe and poorly managed chronic diseases, such as advanced cardiovascular dise... [+4]